Modulation of voltage-gated calcium channels in disease

• LinkedIn
• Twitter

Presentation

Presentation title

Modulation of voltage-gated calcium channels in disease

Author

Professor Gary Stephens

Overview

Presentation from the Metrion Biosciences’ external speaker series, Professor Gary Stephens, University of Reading, 28th November 2016.

Please contact us if you would like any further information regarding our suite of cardiac safety services.

Background

Professor Gary Stephens gave his perspective on his research into calcium channel modulation, cannabinoid-derived anti-epileptic agents; plus biologics and SUMOylation in the field of ion channel modulation as part of Metrion Biosciences External Speaker Series.

Extract from our Interview with Professor Gary Stephens

Calcium channels and synaptic transmission are major components of your research career. What inspired you to focus on these areas and what is the basis of your continued interest?

As a post-doctoral worker with Wyeth Research I was bitten by the ion channel electrophysiology bug. Back then (in the early 90’s) I initially worked on cloned potassium channels which were then not widely accessible, but were made available to Wyeth via an academic collaboration. I wanted to move towards ion channel modulation and subsequently became the first post-doctoral researcher in Annette Dolphin’s group (then based at the Royal Free Hospital site of University College London’s Pharmacology Department) to perform electrophysiological work on cloned channels.

Gary gave the first presentation in Metrion Biosciences External Speaker Series in November 2016, his interview can be found in our ConnectIONS blog article here.

Read more…

Other recommended presentations

• Validation of an impedance-based phenotypic screening assay able to detect multiple mechanisms of chronic cardiotoxicity in human stem cell-derived cardiomyocytes
• M-type K+ channels in nociceptive pathways: physiological roles and therapeutic potential
• In depth profiling of human iPSC cardiomyocytes: From electrophysiology to phenotypic assays
• Utility of human iPSC derived CMs for preclinical safety assays and disease modelling
• Therapeutic potential of activators of two-pore domain ion channels